Propranolol reduces variceal pressure and wall tension in schistosomiasis presinusoidal portal hypertension

Journal of Gastroenterology and Hepatology (Australia)

Volumn 24, Issue 12, 2009, Pages 1852-1856

  Farias, Alberto Queiroz ^a   Kassab, Fabio ^a   Da Rocha, Evandra Cristina Vieira ^a   Dos Santos Bomfim, Valdinélia ^a   Vezozzo, Denise Cerqueira Paranaguá ^a   Bittencourt, Paulo Lisboa ^a   Carrilho, Flair José ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Portal hypertension; Propranolol; Schistosomiasis

Indexed keywords

PROPRANOLOL;

ADULT; ARTERIAL PRESSURE; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE TITRATION; DRUG EFFECT; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPY; ESOPHAGUS VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; LIVER SINUSOID; MALE; PATIENT COMPLIANCE; PORTAL HYPERTENSION; PRESSURE AND TENSION; PRIORITY JOURNAL; PROPHYLAXIS; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

EID: 72149089632     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2009.05912.x     Document Type: Article

References (23)

1. Gryseels B, Polman K, Clerinx J, Kestens L. Human schistosomiasis. Lancet 2006 368 : 1106 1118.
2. World Health Organization (WHO Expert Committee). Prevention and control of schistosomiasis and soil-transmitted helminthiasis. World Health Organ. Tech. Rep. Ser. 2002 912 : 1 57.
3. Mies S, Braghirolli Neto O, Beer A et al. Systemic and hepatic hemodynamics in hepatosplenic Manson's schistosomiasis with and without propranolol. Dig. Dis. Sci. 1997 42 : 751 761.
4. El Tourabi H, el Amin AA, Shaheen M, Woda SA, Homeida M, Harron DW. Propranolol reduces mortality in patients with portal hypertension secondary to schistosomiasis. Ann. Trop. Med. Parasitol. 1994 88 : 493 500.
5. Brett BT, Hayes PC, Jalan R. Primary prophylaxis of variceal bleeding in cirrhosis. Eur. J. Gastroenterol. Hepatol. 2001 13 : 349 358.
6. Tripathi D, Hayes PC. A drug therapy for the prevention of variceal haemorrhage. Aliment. Pharmacol. Ther. 2001 15 : 291 310.
7. The Cairo Working Group (Jenkims JM, Hatz C). The use of diagnostic ultrasound in schistosomiasis - attempts at standardization of methodology. Acta Trop. 1992 51 : 45 63.
8. Richter J, Domingues AL, Barata CH, Prata AA, Lambertucci JR. Report of the second satellite symposium on ultrasound in schistosomiasis. Mem. Inst. Oswaldo Cruz 2001 96 (Suppl. 151 156.
9. Moriyasu F, Nishida O, Ban N et al. Congestion index of the portal vein. AJR 1986 146 : 753 759.
10. Vezozzo DC, Farias AQ, Cerri GG, Da Silva LC, Carrilho FJ. Assessment of portal hemodynamics by Doppler ultrasound and of liver morphology in the hepatosplenic and hepatointestinal forms of schistosomiasis mansoni. Dig. Dis. Sci. 2006 51 : 1413 1419.
11. Idezuki Y. General rules for recording endoscopic findings of esophagogastric varices. Japanese Society for Portal Hypertension. World J. Surg. 1995 19 : 420 422.
12. Bosch J, Bordas JM, Rigau J et al. Noninvasive measurement of the pressure of esophageal varices using an endoscopic gauge: Comparison with measurements by variceal puncture in patients undergoing endoscopic sclerotherapy. Hepatology 1986 6 : 667 672.
13. Rigau J, Bosch J, Bordas JM et al. Endoscopic measurement of variceal pressure in cirrhosis: Correlation with portal pressure and variceal hemorrhage. Gastroenterology 1989 96 : 873 880.
14. Fevery J, Nevens F. Oesophageal varices: Assessment of the risk of bleeding and mortality. J. Gastroenterol. Hepatol. 2000 15 : 842 848.
15. Sarin SK, Sethi KK, Nanda R. Measurement and correlation of wedged hepatic, intrahepatic, intrasplenic and intravariceal pressures in patients with cirrhosis of liver and non-cirrhotic portal fibrosis. Gut 1987 28 : 260 266.
16. Escorsell A, Bordas JM, Feu F et al. Endoscopic assessment of variceal volume and wall tension in cirrhotic patients: Effects of pharmacological therapy. Gastroenterology 1997 113 : 1640 1646.
17. El Atti EA, Nevens F, Bogaerts K, Verbeke G, Fevery J. Variceal pressure is a strong predictor of variceal haemorrhage in patients with cirrhosis as well as in patients with non-cirrhotic portal hypertension. Gut 1999 45 : 618 621.
18. Talwalkar JA, Kamath PS. An evidence-based medicine approach to β-blocker therapy in patients with cirrhosis. Am. J. Med. 2004 116 : 759 766.
19. Garcia-Tsao G, Groszmann RJ, Fisher RL, Conn HO, Aterbury CE, Glickman M. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 1985 5 : 419 424.
20. Nevens F, Sprengers D, Feu F, Bosch J, Fevery J. Measurement of variceal pressure with an endoscopic pressure sensitive gauge: Validation and effect of propranolol therapy in chronic conditions. J. Hepatol. 1996 24 : 66 73.
21. Khuroo MS, Khuroo NS, Farahat KLC, Khuroo YS, Sofis AA, Dahab ST. Meta-analysis: Endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleeding. Aliment Pharmacol Ther 2005 21 : 347 361.
22. Feu F, García-Pagán JC, Bosch J, Luca A, Terés J, Escorsell A, Rodés J. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal hemorrhage in patients with cirrhosis. Lancet 1995 346 : 1056 1059.
23. Homeida MM, Ali HM, Arbab BM, Harron DW. Propranolol disposition in patients with hepatosplenic schistosomiasis. Br. J. Clin. Pharmacol. 1987 24 : 393 396.